Literature DB >> 17237596

The relationship between microbiota and polyamine concentration in the human intestine: a pilot study.

Mitsuharu Matsumoto1, Yoshimi Benno.   

Abstract

The fecal microbiota of 10 hospitalized elderly subjects and 14 healthy adults were analyzed by terminal-restriction fragment length polymorphism (T-RFLP) analysis using Hha I, Msp I, Hae III, and Alu I, as well as fecal polyamine (PA) concentration. The T-RFLP profiles of the fecal microbiota of the subjects were roughly divided into 2 clusters-I (9 out of 11 were derived from hospitalized elderly subjects) and II (12 out of 13 were derived from healthy adults). The average concentration of putrescine in Cluster II was 5.8 times higher than that of putrescine in Cluster I (P=0.0015). Using a phylogenetic assignment database for T-RFLP analysis of human colonic microbiota, the terminal-restriction fragments (T-RFs) characteristically detected in the case of subjects with high fecal PA concentration were predicted to be derived from bacterial species and phylotypes belonging to Clostridium subcluster XIVa, particularly including Clostridium xylanolyticum, Clostridium saccharolyticum, the uncultured human intestinal bacterium clone JW1H4 (a relative of Desulfotomaculum guttoideum), Roseburia intestinalis, the uncultured bacterium clone 41F10 (a relative of Eubacterium ramulus), Roseburia cecicola, Ruminococcus obeum and its relatives. From these results, we concluded that fecal microbiota may be linked with fecal PA concentration and that some bacterial species belonging to Clostridium subcluster XIVa may play a major role in the control of intestinal PA concentration in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237596     DOI: 10.1111/j.1348-0421.2007.tb03887.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  38 in total

1.  Patterns of salivary microbiota injury and oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation.

Authors:  Roni Shouval; Adi Eshel; Bar Dubovski; Amir A Kuperman; Ivetta Danylesko; Joshua A Fein; Shalev Fried; Mika Geva; Elizaveta Kouniavski; Hadar Neuman; Ayelet Armon-Omer; Radi Shahien; Efrat Muller; Cecilia Noecker; Elhanan Borenstein; Yoram Louzoun; Arnon Nagler; Omry Koren
Journal:  Blood Adv       Date:  2020-07-14

2.  Agaro-oligosaccharides: a new frontier in the fight against colon cancer?

Authors:  Yogesh Bhattarai; Purna C Kashyap
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-02-11       Impact factor: 4.052

3.  Potential of Omega-3 Polyunsaturated Fatty Acids in Managing Chemotherapy- or Radiotherapy-Related Intestinal Microbial Dysbiosis.

Authors:  Yue Zhang; Boyan Zhang; Lihua Dong; Pengyu Chang
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

Review 4.  Biochemical Features of Beneficial Microbes: Foundations for Therapeutic Microbiology.

Authors:  Melinda A Engevik; James Versalovic
Journal:  Microbiol Spectr       Date:  2017-10

5.  Dietary polyamine intake and colorectal cancer risk in postmenopausal women.

Authors:  Ashley J Vargas; Erin L Ashbeck; Betsy C Wertheim; Robert B Wallace; Marian L Neuhouser; Cynthia A Thomson; Patricia A Thompson
Journal:  Am J Clin Nutr       Date:  2015-07-01       Impact factor: 7.045

6.  Mechanism for regulation of the putrescine utilization pathway by the transcription factor PuuR in Escherichia coli K-12.

Authors:  Naoki Nemoto; Shin Kurihara; Yuzuru Kitahara; Kei Asada; Kenji Kato; Hideyuki Suzuki
Journal:  J Bacteriol       Date:  2012-04-20       Impact factor: 3.490

Review 7.  Exploring the links among inflammation and gut microbiome with psychoneurological symptoms and gastrointestinal toxicities in gynecologic cancers: a systematic review.

Authors:  Zahra Amirkhanzadeh Barandouzi; Claire Rowcliffe; Julia Schrogin; Rebecca Meador; Deborah Watkins Bruner
Journal:  Support Care Cancer       Date:  2022-04-09       Impact factor: 3.603

Review 8.  The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis.

Authors:  Michel J van Vliet; Hermie J M Harmsen; Eveline S J M de Bont; Wim J E Tissing
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

Review 9.  Gut microbiota and host metabolism in liver cirrhosis.

Authors:  Makoto Usami; Makoto Miyoshi; Hayato Yamashita
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 10.  Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases.

Authors:  Wenjing Yang; Yingzi Cong
Journal:  Cell Mol Immunol       Date:  2021-03-11       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.